StockWatch
·
Pharmaceuticals
Quarterly Result4 Nov 2026, 06:13 pm

Transchem Ltd Declares Unaudited Q2 FY27 Results

AI Summary

Transchem Limited announced its Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results, which were reviewed by the Audit Committee and the Statutory Auditors, Mathur & Co. The company also informed that the trading window for dealing in its securities will remain closed until 48 hours after the declaration of these results. Additionally, the company utilized ₹26.02 crore from proceeds of warrants issued in Q1 FY27 for the acquisition of 100% equity share capital of Greshma Shares & Stocks Limited.

Key Highlights

  • Board approved Unaudited Standalone & Consolidated Financial Results.
  • Results for the quarter and half-year ended September 30, 2026.
  • Statutory Auditors issued an unmodified Review Report.
  • ₹26.02 crore utilized for acquisition of Greshma Shares & Stocks Ltd.
  • Trading window closed until 48 hours post-results declaration.